These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 18585497)

  • 1. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.
    Rietbrock S; Heeley E; Plumb J; van Staa T
    Am Heart J; 2008 Jul; 156(1):57-64. PubMed ID: 18585497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older.
    Morillas P; Pallarés V; Fácila L; Llisterri JL; Sebastián ME; Gómez M; Castilla E; Camarasa R; Sandin M; García-Honrubia A;
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):485-91. PubMed ID: 25487320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
    Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHADS2 Scores as a Predictor of Ischemic Stroke in Patients With Peripheral Artery Disease.
    Yang YW; Chen YH; Hsu CC; Lee CC; Kuo YH; Chuang HY; Hsieh TF
    Mayo Clin Proc; 2016 Jan; 91(1):45-50. PubMed ID: 26678007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Tuan TC; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Hsieh MH; Lip GY; Chen SA
    Mayo Clin Proc; 2016 May; 91(5):567-74. PubMed ID: 27068667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation.
    Ntaios G; Lip GY; Lambrou D; Papavasileiou V; Manios E; Milionis H; Spengos K; Makaritsis K; Vemmos K
    Neurology; 2015 Mar; 84(12):1213-9. PubMed ID: 25695964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and geographic differences in CAD risk factors and CHADS2 scores in atrial fibrillation patients.
    Bhardwaj R; Sharma P; Finkel MS; Jain S; Arham A; Kazmi T; Beto RJ; Gharib W; Warden BE; Jain AC
    W V Med J; 2012; 108(1):18-21. PubMed ID: 25134188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CHADS
    Kondo T; Yamada T; Morita T; Furukawa Y; Tamaki S; Iwasaki Y; Kawasaki M; Kikuchi A; Kawai T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    Heart Vessels; 2017 Feb; 32(2):193-200. PubMed ID: 27325225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
    Mitchell LB; Southern DA; Galbraith D; Ghali WA; Knudtson M; Wilton SB;
    Heart; 2014 Oct; 100(19):1524-30. PubMed ID: 24860007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting.
    Chan PH; Wong CK; Pun L; Wong YF; Wong MM; Chu DW; Siu CW
    BMJ Open; 2017 Jun; 7(6):e013685. PubMed ID: 28619766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of risk stratification according to CHADS2 score in Japanese patients with nonvalvular atrial fibrillation.
    Masaki N; Suzuki M; Iwatsuka R; Mizukami A; Kumasaka L; Nagahori W; Ohno M; Matsumura A; Maruyama Y; Hashimoto Y
    Int Heart J; 2009 May; 50(3):323-9. PubMed ID: 19506336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of ischemic stroke or transient ischemic attack in patients with multiple risk factors with or without atrial fibrillation: a retrospective cohort study.
    Yuan Z; Makadia R; Ryan P; Yannicelli D; Nessel C; Sarich T
    Curr Med Res Opin; 2015; 31(7):1257-66. PubMed ID: 25877807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
    Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
    Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
    Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C
    Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.